Fifth Third Bancorp Has $6.96 Million Holdings in Cencora, Inc. $COR

Fifth Third Bancorp boosted its holdings in Cencora, Inc. (NYSE:COR) by 16.2% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 20,611 shares of the company’s stock after buying an additional 2,877 shares during the quarter. Fifth Third Bancorp’s holdings in Cencora were worth $6,961,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in the company. Vestcor Inc boosted its stake in shares of Cencora by 0.5% during the third quarter. Vestcor Inc now owns 5,196 shares of the company’s stock valued at $1,624,000 after purchasing an additional 28 shares in the last quarter. JFS Wealth Advisors LLC boosted its stake in shares of Cencora by 30.2% during the fourth quarter. JFS Wealth Advisors LLC now owns 125 shares of the company’s stock valued at $42,000 after purchasing an additional 29 shares in the last quarter. Cornerstone Wealth Group LLC boosted its stake in shares of Cencora by 1.3% during the third quarter. Cornerstone Wealth Group LLC now owns 2,383 shares of the company’s stock valued at $745,000 after purchasing an additional 30 shares in the last quarter. Apollon Wealth Management LLC boosted its stake in shares of Cencora by 0.5% during the fourth quarter. Apollon Wealth Management LLC now owns 6,527 shares of the company’s stock valued at $2,205,000 after purchasing an additional 30 shares in the last quarter. Finally, Vermillion & White Wealth Management Group LLC boosted its stake in shares of Cencora by 31.4% during the third quarter. Vermillion & White Wealth Management Group LLC now owns 138 shares of the company’s stock valued at $43,000 after purchasing an additional 33 shares in the last quarter. 97.52% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of brokerages have recently commented on COR. Wells Fargo & Company lifted their price target on Cencora from $405.00 to $429.00 and gave the company an “overweight” rating in a research note on Tuesday, February 10th. Leerink Partners reissued an “outperform” rating on shares of Cencora in a research note on Tuesday, March 17th. Barclays lifted their price target on Cencora from $400.00 to $425.00 and gave the company an “overweight” rating in a research note on Friday, February 13th. Jefferies Financial Group raised Cencora from an “underperform” rating to a “buy” rating in a research note on Thursday, January 22nd. Finally, William Blair began coverage on Cencora in a research note on Tuesday. They set a “market perform” rating on the stock. Twelve research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $398.17.

Cencora Price Performance

Shares of COR opened at $304.18 on Friday. Cencora, Inc. has a 1 year low of $271.00 and a 1 year high of $377.54. The company has a debt-to-equity ratio of 3.62, a current ratio of 0.92 and a quick ratio of 0.51. The company has a market capitalization of $59.17 billion, a price-to-earnings ratio of 36.56, a price-to-earnings-growth ratio of 1.42 and a beta of 0.65. The business has a 50-day moving average of $333.36 and a 200-day moving average of $343.13.

Cencora (NYSE:COR) last issued its quarterly earnings data on Wednesday, February 4th. The company reported $4.08 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.04 by $0.04. Cencora had a return on equity of 176.54% and a net margin of 0.50%.The company had revenue of $85.93 billion during the quarter, compared to the consensus estimate of $86.12 billion. During the same period last year, the company earned $3.73 earnings per share. The firm’s revenue was up 5.5% compared to the same quarter last year. As a group, equities research analysts anticipate that Cencora, Inc. will post 17.56 earnings per share for the current year.

Cencora Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, March 2nd. Stockholders of record on Friday, February 13th were given a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date was Friday, February 13th. Cencora’s dividend payout ratio (DPR) is 28.85%.

About Cencora

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.